Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa
ConditionHidradenitis Suppurativa (HS)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-75
SponsorGeisinger Clinic
About this trial
The purpose of this study is to evaluate whether Alexandrite laser treatment is non-inferior to Nd:YAG (neodymium-doped yttrium aluminum garnet) laser treatment of hidradenitis suppurativa (HS).
Eligibility criteria
Qualifiers
Geisinger male or female patients with a diagnosis of hidradenitis suppurativa (all stages of disease)
12-75 years of age
Not on concurrent systemic therapy (e.g., antibiotics, biologic therapies)
Must have not used systemic therapies within 2 weeks of enrollment in study
Disqualifiers
Patients who cannot tolerate laser therapy
Patients who cannot wear protective eyewear
Patients who are pregnant
Trial design
Treatments tested in this trial
- Nd:YAG Laser
- Alexandrite Laser
Treatment groups
21 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov